GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (TSXV:IPCI) » Definitions » Cyclically Adjusted Book per Share

IntelliPharmaCeutics International (TSXV:IPCI) Cyclically Adjusted Book per Share : C$0.21 (As of Aug. 2023)


View and export this data going back to 1999. Start your Free Trial

What is IntelliPharmaCeutics International Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

IntelliPharmaCeutics International's adjusted book value per share for the three months ended in Aug. 2023 was C$-0.524. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is C$0.21 for the trailing ten years ended in Aug. 2023.

During the past 12 months, IntelliPharmaCeutics International's average Cyclically Adjusted Book Growth Rate was 75.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 2.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of IntelliPharmaCeutics International was 2.50% per year. The lowest was -63.20% per year. And the median was -36.00% per year.

As of today (2024-05-21), IntelliPharmaCeutics International's current stock price is C$0.08. IntelliPharmaCeutics International's Cyclically Adjusted Book per Share for the quarter that ended in Aug. 2023 was C$0.21. IntelliPharmaCeutics International's Cyclically Adjusted PB Ratio of today is 0.38.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of IntelliPharmaCeutics International was 18.83. The lowest was 0.28. And the median was 2.08.


IntelliPharmaCeutics International Cyclically Adjusted Book per Share Historical Data

The historical data trend for IntelliPharmaCeutics International's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International Cyclically Adjusted Book per Share Chart

IntelliPharmaCeutics International Annual Data
Trend Nov13 Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.48 0.13 -0.14 0.04 0.14

IntelliPharmaCeutics International Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.14 0.18 0.20 0.21

Competitive Comparison of IntelliPharmaCeutics International's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, IntelliPharmaCeutics International's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IntelliPharmaCeutics International's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's Cyclically Adjusted PB Ratio falls into.



IntelliPharmaCeutics International Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, IntelliPharmaCeutics International's adjusted Book Value per Share data for the three months ended in Aug. 2023 was:

Adj_Book= Book Value per Share /CPI of Aug. 2023 (Change)*Current CPI (Aug. 2023)
=-0.524/125.3885*125.3885
=-0.524

Current CPI (Aug. 2023) = 125.3885.

IntelliPharmaCeutics International Quarterly Data

Book Value per Share CPI Adj_Book
201311 -2.914 97.182 -3.760
201402 3.340 98.051 4.271
201405 3.351 99.394 4.227
201408 2.616 99.315 3.303
201411 2.370 99.078 2.999
201502 2.225 99.078 2.816
201505 1.518 100.263 1.898
201508 1.279 100.579 1.594
201511 -0.075 100.421 -0.094
201602 -0.594 100.421 -0.742
201605 -1.017 101.765 -1.253
201608 0.787 101.686 0.970
201611 0.503 101.607 0.621
201702 0.379 102.476 0.464
201705 0.359 103.108 0.437
201708 -0.322 103.108 -0.392
201711 0.142 103.740 0.172
201802 -0.988 104.688 -1.183
201805 -0.304 105.399 -0.362
201808 -1.486 106.031 -1.757
201811 0.297 105.478 0.353
201902 0.055 106.268 0.065
201905 -0.061 107.927 -0.071
201908 -0.145 108.085 -0.168
201911 -0.221 107.769 -0.257
202002 -0.271 108.559 -0.313
202005 -0.343 107.532 -0.400
202008 -0.262 108.243 -0.303
202011 -0.349 108.796 -0.402
202102 -0.385 109.745 -0.440
202105 -0.184 111.404 -0.207
202108 -0.235 112.668 -0.262
202111 -0.310 113.932 -0.341
202202 -0.346 115.986 -0.374
202205 -0.383 120.016 -0.400
202208 -0.396 120.569 -0.412
202211 -0.430 121.675 -0.443
202302 -0.444 122.070 -0.456
202305 -0.449 124.045 -0.454
202308 -0.524 125.389 -0.524

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


IntelliPharmaCeutics International  (TSXV:IPCI) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

IntelliPharmaCeutics International's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.08/0.21
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of IntelliPharmaCeutics International was 18.83. The lowest was 0.28. And the median was 2.08.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


IntelliPharmaCeutics International Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


IntelliPharmaCeutics International (TSXV:IPCI) Business Description

Traded in Other Exchanges
Address
30 Worcester Road, Toronto, ON, CAN, M9W 5X2
IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.

IntelliPharmaCeutics International (TSXV:IPCI) Headlines

No Headlines